The Journal of Clinical Endocrinology and Metabolism Journal Article

Body Composition Differentiates Prediabetes Phenotype Clusters in the Diabetes Prevention Program Study

November 04, 2025
 

Benjamin M Stroebel, Meghana Gadgil, Kimberly A Lewis, Kayla D Longoria, Li Zhang, Elena Flowers
The Journal of Clinical Endocrinology & Metabolism, Volume 110, Issue 11, November 2025, Pages e3665–e3672
https://doi.org/10.1210/clinem/dgaf163

Abstract

Context

Type 2 diabetes (T2D) remains a significant public health problem, and current approaches to risk reduction fail to adequately prevent T2D in all individuals.

Objective

The purpose of this study was to apply clustering methods that include metabolic risk factors and body composition measures to identify and characterize prediabetes phenotypes and their relationships with treatment arm and incident T2D.

Design

Secondary analysis of the Diabetes Prevention Program clinical trial.

Setting

Previously completed Diabetes Prevention Program trial.

Patients or Other Participants

Subset of participants (n = 994) with body composition measures.

Interventions

Not applicable.

Main Outcome Measures

Unsupervised k-means clustering analysis was applied to derive the optimal number of clusters of participants based on common clinical risk factors alone or common risk factors plus more comprehensive measures of glucose tolerance and body composition.

Results

Five clusters were derived from both the common clinical characteristics and the addition of comprehensive measures of glucose tolerance and body composition. Within each modeling approach, participants showed significantly different levels of individual risk factors. The clinical only model showed higher accuracy for time to T2D; however, the more comprehensive models further differentiated an overweight phenotype by overall metabolic health. For both models, the greatest differentiation in determining time to T2D was in the metformin arm of the trial.

Conclusion

Data-driven clustering of patients with prediabetes allows for identification of prediabetes phenotypes at greater risk for disease progression and responses to risk reduction interventions. Further investigation into phenotypic differences in treatment response could enable better personalization of prediabetes and T2D prevention and treatment choices.

Read the article

 

You may also like...

Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.

Thematic Issue

Latest Thematic Issue

immuno-endocrinology
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.